Unknown

Dataset Information

0

Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study.


ABSTRACT: Hepatitis C virus (HCV) causes persistent infection in 75% of cases and is a major public health problem worldwide. More than 92% of intravenous drug users (IDU) infected by human immunodeficiency virus type 1 (HIV-1) are seropositive for HCV, and it is conceivable that some HIV-1-infected IDU who remain uninfected by HCV may be genetically resistant.Here we conducted a case-control study to identify mutations in HCV entry coreceptors in HIV-infected IDU who remained uninfected by HCV. We recruited 138 patients, comprising 22 HIV+ HCV- case IDU and 116 HIV+ HCV+ control IDU. We focused on coreceptors in which point mutations are known to abolish HCV infectivity in vitro. Our previous study of the Claudin-1 gene revealed no specific variants in the same case population. Here we performed direct genomic sequencing of the Claudin-6, Claudin-9, Occludin and Scavenger receptor-B1 (SCARB1) gene coding regions. Most HIV+ HCV- IDU had no mutations in HCV coreceptors. However, two HIV+ HCV- patients harbored a total of four specific mutations/variants of HCV entry factors that were not found in the HIV+ HCV+ controls. One case patient harbored heterozygous variants of both Claudin-6 and Occludin, and the other case patient harbored two heterozygous variants of SCARB1. This suggests that HCV resistance might involve complex genetic events and factors other than coreceptors, a situation similar to that reported for HIV-1 resistance.

SUBMITTER: Fouquet B 

PROVIDER: S-EPMC4646460 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study.

Fouquet Baptiste B   Ghosn Jade J   Quertainmont Yann Y   Salmon Dominique D   Rioux Christophe C   Duvivier Claudine C   Delfraissy Jean-François JF   Misrahi Micheline M  

PloS one 20151116 11


Hepatitis C virus (HCV) causes persistent infection in 75% of cases and is a major public health problem worldwide. More than 92% of intravenous drug users (IDU) infected by human immunodeficiency virus type 1 (HIV-1) are seropositive for HCV, and it is conceivable that some HIV-1-infected IDU who remain uninfected by HCV may be genetically resistant.Here we conducted a case-control study to identify mutations in HCV entry coreceptors in HIV-infected IDU who remained uninfected by HCV. We recrui  ...[more]

Similar Datasets

| S-EPMC4643007 | biostudies-literature
| S-EPMC3194089 | biostudies-literature
| S-EPMC4352077 | biostudies-literature
| S-EPMC3198807 | biostudies-literature
| S-EPMC4334806 | biostudies-literature
| S-EPMC8248640 | biostudies-literature
| S-EPMC7413399 | biostudies-literature
| S-EPMC8394142 | biostudies-literature
| S-EPMC4990822 | biostudies-other
| S-EPMC3690562 | biostudies-literature